Research & Perspectives

1. ADCs As Biological Missiles For Targeted Therapies 6/15/2026

   Antibody-drug conjugates are reshaping cancer treatment. Learn how monoclonal antibody targeting, linker design, and next-gen payloads are defining the future of precision oncology.

2. Tech Transfer In CDMOs: Avoiding The Scale-Up Trap 6/15/2026

   Tech transfer at a CDMO is a stress test, not a handover. Learn why lab-ready processes fail at scale and what chemical process development must address before manufacturing starts.

3. Batch Manufacturing Vs Continuous Manufacturing With Process Analytical Technology 6/15/2026

   Batch or continuous manufacturing? The answer depends heavily on how you use process analytical technology. Understand the tradeoffs before your next program decision.

4. Self-Amplifying RNA: The Next Chapter In mRNA Therapeutics 6/5/2026

   Self-amplifying RNA builds on mRNA technology by enabling intracellular replication, delivering stronger and longer-lasting responses at lower doses while improving scalability, cost-efficiency, and global accessibility.

5. How Integrated Molecule Innovation Is Transforming Vet Therapeutics 5/27/2026

   Cell line development underpins modern animal health innovation, enabling production of targeted biologics and supporting integrated approaches that improve therapeutic precision, scalability, and treatment outcomes.

6. Balancing Timelines In Outsourced R&D With GXP Compliance 5/27/2026

   Outsourced R&D balances speed and quality by integrating strong governance, clear planning, and GXP compliance, enabling efficient execution while reducing risk, rework, and development delays.

7. How AI Is Reshaping CRDMOs 5/27/2026

   Artificial intelligence is transforming CRDMOs by improving risk prediction, process efficiency, and decision-making, enabling more predictable, data-driven drug development and manufacturing across the lifecycle.

8. Decoding The FDA's AMT Program Through Process Analytical Technology 5/27/2026

   Process analytical technology enables real-time monitoring and control in pharmaceutical manufacturing, supporting FDA advanced manufacturing initiatives to improve efficiency, product quality, and supply reliability.

9. A Viral Testing Facility – Striving For Excellence 5/27/2026

   A GLP-certified viral testing facility ensures biologics safety through comprehensive detection and clearance services, supporting compliance and consistent production of high-quality therapeutics.

10. Gene To GMP-Grade Clinical Supply In 9 Months 5/27/2026

    An integrated, platform-based approach enables rapid biologics development, cutting gene-to-GMP timelines to nine months through optimized processes, data-driven design, and streamlined scale-up.